It’s July 20, 1969. Neil Armstrong and Buzz Aldrin are about to land on the moon. They will be the first humans to set foot ...

Security researchers have discovered 10 new indirect prompt injection (IPI) payloads targeting AI agents with malicious instructions designed to achieve financial fraud, data destruction, API key ...

A handful of useful productivity tools wrapped up in a simple shell script.

Recursion can feel like magic until you understand its simple rules: a base case to stop, and a recursive call to repeat. By breaking problems into smaller versions of themselves, recursion makes ...

The Devil Wears Prada 2 is the sequel to a film that launched a thousand memes. For the film’s New York premiere in April ...

Recursion Pharmaceuticals, Inc. remains a Hold as competitive risks persist and the company is years away from meaningful pipeline revenue. RXRX's AI-driven Recursion OS platform shows strong ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Midlevel leadership judgment is the real control system when AI tools move from demo to ...

Vibe coding is a truly revolutionary democratizer of software development. It allows anyone with a computer and a little imagination to come up with software that appears, at least on the surface, to ...

Autonomous agents are compressing software delivery timelines from weeks to days. The enterprises that scale agents safely will be the ones that build using spec-driven development. There’s a moment ...

At Google, leaders are anxious about falling behind in the race to offer AI coding tools, especially as rivals like Anthropic PBC offer more effective and popular tools to businesses, according to ...

In the wake of a major takedown of phishing's biggest brand name, Tycoon 2FA, phishers worldwide have scattered. Some have stuck around, but many have moved to other phishing service providers, and ...

Good afternoon, everyone, and thank you for joining us on the first day of Needham & Company Healthcare Conference. My name is Gil Blum, and I'm a senior biotech analyst here at Needham & Company. It ...